AzTrials
AzTrials

Knee OsteoarthritisNCT06757946

Effect of Mulligan Medial/Lateral Glide w/wo Compression/Decompression Technique on Pain ROM and Function KO

A study testing Mulligan Medial/Lateral glide with compression/ decompression technique and Mulligan Medial/Lateral glide in people with Knee Osteoarthritis, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The Effect of Mulligan Medial/Lateral Glide Techniques with and without Compression-Decompression on Pain, Range of Motion and Function in Patients with Knee Osteoarthritis. This study aims to investigate these effects to develop more effective, non-invasive treatment protocols for improving pain, range of motion and… Read more about this study

Who is it for?
Ages 30 to 60 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Mulligan Medial/Lateral glide with compression/ decompression technique and Mulligan Medial/Lateral glide
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 sitePakistan
Study dates
15 Feb 2024to 1 Mar 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Unilateral Knee OA, Males and females between 30 and 60 years of age,
  • Patients with restricted ROM,
  • Patients are having more than grade III strength of knee muscles,
  • l Willingness to take part in the intervention and evaluations

Who cannot join

  • Patients having unstable knee joint after Total Knee Arthroplasty or medical conditions affecting rehabilitation,
  • l Joint infection of hip and knee,
  • l Soft tissue injuries around knee joints,
  • including tendinitis and bursitis,
  • l Any fracture including patellar fracture, femur or tibia

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Services Hospital, Shadman 1

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Official title: Effect of Mulligan Medial/Lateral Glide With and Without Compression/ Decompression Technique on Pain, Range of Motion and Function on Patients With Knee Osteoarthritis

The Effect of Mulligan Medial/Lateral Glide Techniques with and without Compression-Decompression on Pain, Range of Motion and Function in Patients with Knee Osteoarthritis. This study aims to investigate these effects to develop more effective, non-invasive treatment protocols for improving pain, range of motion and overall function in knee OA

Read the detailed description

patients, for the better understanding of response by both treatments (i.e Mulligan medial/lateral glide with and without compression/decompression technique). Patient which meet inclusion criteria, gave their consent.

Being tested
Mulligan Medial/Lateral glide with compression/ decompression technique, Mulligan Medial/Lateral glide
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mulligan Medial/Lateral glide with compression/ decompression techniqueCombination product

    Warm up (10 minutes with hot pack) and cool down exercises for a period of 5 to 10 minutes was given before starting and after the completion of exercises in supervised exercise program in all the groups. The following ergonomical advice were given to all the subjects, Avoid extreme knee bent positions, avoid squatting, crossed-leg sitting, frequent stair climbing or lifting heavy objects, avoid fatiguing postures except for infrequent short durations tasks, change posture frequently and use support where possible and avoid giving excess strain to the knees.

    Mulligan mobilisation consisted of Medial glide mobilisation with movement, Lateral glide mobilisation with movement, with active knee flexion (61) depending on the subjects condition. The gliding force was sustained while the patient performed 3 sets of 10 repetitions.

    Total 12 treatment sessions was given to each subject with the frequency of 3 sessions per week for 4 consecutive weeks.

  • Mulligan Medial/Lateral glideCombination product

    Warm up (10 minutes with hot pack) and cool down exercises for a period of 5 to 10 minutes was given before starting and after the completion of exercises in supervised exercise program in all the groups. The following ergonomical advice were given to all the subjects, Avoid extreme knee bent positions, avoid squatting, crossed-leg sitting, frequent stair climbing or lifting heavy objects, avoid fatiguing postures except for infrequent short durations tasks, change posture frequently and use support where possible and avoid giving excess strain to the knees.

    Total 12 treatment sessions was given to each subject with the frequency of 3 sessions per week for 4 consecutive weeks. After completing the therapeutic session, post- intervention data of the outcome parameters were taken.

Study groups in NCT06757946
Study groupRoleWhat they receive
Interventional group IExperimentalNot described
Receives: Combination Product: Mulligan Medial/Lateral glide with compression/ decompression technique
Interventional group IIActive comparatorNot described
Receives: Combination Product: Mulligan Medial/Lateral glide

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Rating Scale (NPRS)

    This tool was utilized to assess the intensity of pain. A score of 0 denotes ""having no pain at all,"" while a score of 10 indicates ""the worst pain I've ever experienced."" The participants were asked to choose a number on the scale that accurately represented how much knee discomfort they were experiencing.According to a study conducted on individuals with knee OA, the interclass correlation was 0.95. Higher scores denote more intense pain; scores range from 0 to 10.

    Measured: 12 Months

  2. Western Ontario and McMaster Osteoarthritis Index (WOMAC)

    It is commonly used to assess lower extremity functional status, discomfort, and associated stiffness. The questionnaire consists of twenty-four questions: seventeen pertain to physical status, five concern pain status, and two address stiffness. Each question contains five alternatives starting from 0 which signifies no symptom or trouble at all to 4 which represents considerable difficulty in doing activities with severe symptoms. There are subscale scores for stiffness, discomfort, and functional status. The sum of the 24 items that were listed, with scores ranging from 0 to 96, was the definition of the total scores.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2025
  2. Study start15 Feb 2024
  3. Primary completion1 Aug 2024
  4. Study completion1 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06757946
Sponsor's protocol ID
MSRSW/Batch-Fall22/761
Status last verified
Dec 2024
First submitted
26 Dec 2024
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mulligan Medial/Lateral glide with compression/ decompression technique and Mulligan Medial/Lateral glide in people with Knee Osteoarthritis, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Rating Scale (NPRS) (time frame: 12 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in